Bioequivalence Study of Velpatasvir/Sofosbuvir Oral Coated Tablets in Healthy Volunteers Under Fasting Conditions
Clinical Pharmacology in Drug Development · 2024
DOI: 10.1002/cpdd.1435 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Clinical Pharmacology in Drug Development, 2024. Verfasst von Sergei Noskov und 5 weiteren Autor:innen. Beteiligte Einrichtung: City Hospital No. 3, Yaroslavl, Russia. Hauptthemen laut MEDLINE: Sofosbuvir, Therapeutic Equivalency, Cross-Over Studies, Carbamates. Die Arbeit nennt 24 Literaturangaben. Gefördert von: GEROPHARM, Russia.
Abstract (Originalsprache)
This study was conducted as a single‐site, open‐label, randomized, replicated crossover trial with 4 treatment periods. The aim was to evaluate the bioequivalence of a generic test drug containing velpatasvir and sofosbuvir compared to an established brand‐name medication in healthy White subjects under fasting conditions. Blood samples were collected at specified intervals up to 72 hours after dosing to measure the concentrations of velpatasvir and sofosbuvir using a certified high‐performance liquid chromatography with tandem mass spectrometry method. The bioequivalence of the 2 formulations was confirmed when statistical analysis showed that confidence intervals for the log‐transformed peak concentration and area under the concentration‐time curve from time 0 to the last quantifiable sample were within an acceptable range from 80% to 125%. Criteria for bioequivalence were met for both area under the concentration‐time curve from time 0 until the last quantifiable sample and peak concentration parameters. No adverse effects were reported during this trial in both groups.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- City Hospital No. 3, Yaroslavl, Russia.
- R&D Center, GEROPHARM, Saint-Petersburg, Russia.
Förderung
- GEROPHARM, Russia
Zitieren
APA
Noskov, S., Arefeva, A., Radaeva, K., Makarenko, I., Gefen, M., & Drai, R. (2024). Bioequivalence Study of Velpatasvir/Sofosbuvir Oral Coated Tablets in Healthy Volunteers Under Fasting Conditions. Clinical Pharmacology in Drug Development. https://doi.org/10.1002/cpdd.1435
Vancouver
Noskov S, Arefeva A, Radaeva K, Makarenko I, Gefen M, Drai R. Bioequivalence Study of Velpatasvir/Sofosbuvir Oral Coated Tablets in Healthy Volunteers Under Fasting Conditions. Clinical Pharmacology in Drug Development. 2024. doi:10.1002/cpdd.1435
BibTeX
@article{Noskov2024,
author = {Noskov, Sergei and Arefeva, Anna and Radaeva, Kseniia and Makarenko, Igor and Gefen, Maria and Drai, Roman},
title = {Bioequivalence Study of Velpatasvir/Sofosbuvir Oral Coated Tablets in Healthy Volunteers Under Fasting Conditions},
journal = {Clinical Pharmacology in Drug Development},
year = {2024},
doi = {10.1002/cpdd.1435}
}
EUVIMED